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Gemma Vilagut.Few data are available to estimate the prevalence of eating disorders (EDs) and their correlates in the
community. This paper reports data on EDs obtained in the framework of the ESEMeD project, aimed
at investigating the prevalence of non-psychotic mental disorders in six European countries (Belgium,
France, Germany, Italy, the Netherlands and Spain), using a new version of the Composite International
Diagnostic Interview. The ESEMeD study was a general population cross-sectional household survey. In
total, 21,425 respondents aged 18 or older provided data for the project between January 2001 and
August 2003. A subsample (N = 4139) underwent a detailed investigation on EDs. Lifetime estimated
prevalence of anorexia nervosa, bulimia nervosa, binge eating disorder, sub-threshold binge eating disor-
der, and any binge eating were 0.48%, 0.51%, 1.12%, 0.72%, and 2.15%, respectively, and they were 3–8
times higher among women for all EDs. However, since people under 18 were excluded from this study,
our prevalence should be taken as lower-bound estimate of real frequencies. Indeed, cumulative lifetime
prevalence analysis showed that the majority of eating disorders had their initial onset between 10 and
20 years of age. Role impairment and comorbidity with other mental disorders were highly common, yet
only small proportions of patients with a lifetime diagnosis of EDs requested medical treatment. It still
has to be proven whether early diagnostic identification and access to specialized care can reduce the
burden caused by these disorders.
 2009 Elsevier Ltd. All rights reserved.1. Introduction
Current diagnostic classifications recognize two main eating
disorders (EDs), anorexia nervosa and bulimia nervosa, with symp-
tomatic variants recorded as a global ‘‘not otherwise specified”
class (APA, 1994; WHO, 1992). The binge ED has been proposed
as a possible additional clinical category (Spitzer et al., 1992).
The status of sub-threshold disorders is still debated: several stud-
ies have shown that sub-threshold disorders may cause lessll rights reserved.
. de Girolamo).
Matthias Angermeyer, Sebas-
iovanni de Girolamo, Ron de
ia Haro, Steven J. Katz; Ronald
rmel, Gabriella Polidori, andimpairment and disability than full-blown disorders (Hudson
et al., 2007), but other reports seem to indicate some kind of pro-
gression of sub-threshold disorders (Patton et al., 1999), therefore
representing important antecedents of anorexia and bulimia
nervosa.
Few data are available to estimate the prevalence of EDs. Most
studies have concentrated on single samples selected at local level,
or have investigated symptoms’ distribution by means of question-
naires rather than personal interviews (Hoek and Van Hoeken,
2003; Miotto et al., 2003; Vega Alonso et al., 2005). Point preva-
lence of anorexia nervosa has been reported around 0.3% in Amer-
ican and European studies (Hoek and Van Hoeken, 2003; Favaro
et al., 2004), with lifetime prevalence approximating 0.5–0.6% in
two large population-based surveys in the United State (US) and
Canada (Garfinkel et al., 1996; Walters and Kendler, 1995), and
reaching 1% in a very large population survey in the Netherlands
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estimated to range between 1% and 3% in three large surveys in
New Zealand, the US and Canada (Bushnell et al., 1990; Garfinkel
et al., 1995; Kendler et al., 1991), but as low as 0.6% in the Nether-
lands (Bijl et al., 1998).
Male/female ratios have been found to range from 1:5 to 1:10
for both anorexia and bulimia nervosa (Bushnell et al., 1990; Gar-
finkel et al., 1995, 1996), although one large-scale survey, carried
out in a national representative sample of US citizens, found higher
prevalence among males than in past studies, resulting in a lower
female/male ratio (Hudson et al., 2007). With regard to binge ED,
data are sparse, with estimated prevalence around 3.3% among wo-
men and 0.8% among men in a large-scale population-based sur-
vey, conducted with telephone interviews in Austria (Kinzl et al.,
1999), and, respectively, 3.5% and 2.0% in the US National Comor-
bidity Replication study (NCS-R) (Hudson et al., 2007).
This paper reports prevalence estimates of EDs obtained in the
framework of the European Study of the Epidemiology of Mental
Disorders (ESEMeD) project (ESEMeD/MHEDEA 2000 Investigators,
2004a, 2004b), part of the World Mental Health (WMH) Survey ini-
tiative, aimed at investigating the prevalence of major mental dis-
orders in six European countries (Belgium, France, Germany, Italy,
the Netherlands and Spain), using a new version of the Composite
International Diagnostic Interview (CIDI 3.0).
The aims of this study were: (i) to investigate the lifetime and
12-month prevalence of EDs, taking into account three main diag-
nostic entities (e.g., anorexia nervosa, bulimia nervosa, and binge
ED) and two sub-threshold categories (sub-threshold binge ED
and binge eating per se); (ii) to describe the major correlates of
these diagnostic entities in terms of impairment in role functioning
and comorbidity with other mental disorders; and (iii) to assess
service use by affected people.2. Methods
2.1. Sample
The study was cross-sectional in nature and individuals were
assessed in person at their homes using computer-assisted inter-
view (CAPI) techniques. The target population was the non-institu-
tionalized adult population (aged 18 years or older) of Belgium,
France, Germany, Italy, the Netherlands and Spain, that is a total
of 212,000,000 European citizens. A stratified, multistage, clustered
area, probability sample design was used.
In total 21,425 respondents provided data for the project be-
tween January 2001 and August 2003. All subjects gave written in-
formed consent for participation after the nature of the procedures
had been fully explained, as approved by the Ethical Review Boards
of the participating countries. Further description of the sampling
frame and selection is provided elsewhere (ESEMeD/MHEDEA
2000 Investigators, 2004b).
The overall response rate in the six countries investigated was
61.2%, with the highest rates in Spain (78.6%) and Italy (71.3%),
and lower rates in Germany (57.8%), the Netherlands (56.4%), Bel-
gium (50.6%) and France (45.9%).
Respondents underwent a detailed interview, based on the ver-
sion 3.0 of the World Health Organization Composite International
Diagnostic Interview (CIDI) (Kessler and Ustun, 2004). For the ESE-
MeD study, a revised and further enhanced version of the CIDI, was
developed and adapted by the Coordinating Committee of the
WHO–WMH Survey Initiative (Haro et al., 2006). This version
was first produced in English and underwent a rigorous process
of adaptation in order to obtain conceptually and cross-culturally
comparable versions in each of the target countries and languages.
This process included forward and backward translations, a reviewby a panel of experts, pretesting using interview and debriefing
techniques and the conduct of focus groups.
A two-phase interview procedure was used. The first phase con-
tained the diagnostic assessment of the most common mood and
anxiety disorders, health-related quality of life, health services uti-
lization and main demographic characteristics. Those who ex-
ceeded a predetermined number of symptoms of specific mood
or anxiety disorders, and a random 25% of the rest, received the
second phase questionnaire (part 2 respondents, N = 8796), which
included an in-depth interview about additional mental disorders,
like PTSD, and correlates, amongst other information. The full diag-
nostic algorithms, and the corresponding CIDI questions used to
operationalize the criteria are available online at www.hcp.med.
harvard.edu/ncs.
The analyses reported here were carried out in sub-sample
part-2 respondents (N = 4139), who were randomly selected to un-
dergo an assessment of EDs.
Individuals were weighted to adjust for the differential proba-
bilities of selection for the second phase and differential probabil-
ities within household. Additional post-stratification weights were
applied to restore age and gender distribution of the population
within each country and the relative population size of the partic-
ipating countries.
2.2. Diagnostic instruments
Diagnoses were based on version 3.0 of the World Health Orga-
nization Composite International Diagnostic Interview (CIDI 3.0), a
fully structured lay administered diagnostic interview that gener-
ates diagnoses according to both the ICD-10 and DSM-IV criteria
(Haro et al., 2006; Kessler and Ustun, 2004). DSM-IV criteria were
used in the current report (APA, 1994).
2.2.1. Assessment of EDs
However, some adaptations were used in the diagnostic pro-
cess: for binge eating episodes in bulimia nervosa and binge ED,
DSM-IV requires the presence of loss of control, and for binge ED
requires a marked distress regarding binge eating; these items
were assessed in the CIDI 3.0 by a series of questions about atti-
tudes and behaviours that are indicators of loss of control and dis-
tress, rather than by direct questioning about loss of control and
marked distress during binge eating.
The full diagnostic algorithms for all three disorders are avail-
able at www.hcp.med.harvard.edu/ncs/diagnosis.php; the corre-
sponding CIDI questions used to operationalize the criteria are
available online at www.hcp.med.harvard.edu/ncs.
We also defined 2 provisional entities. The first was ‘‘sub-
threshold binge ED”, defined as (a) binge eating episodes, (b)
occurring at least twice a week for at least 3 months, and (c) not
occurring solely during the course of anorexia nervosa, bulimia
nervosa, or binge ED. Therefore, sub-threshold binge ED did not re-
quire DSM-IV criterion B (e.g., 3 of 5 features associated with binge
eating, such as eating more rapidly than normal, eating until being
unpleasantly full, eating great quantity of food even without being
hungry, eating in solitude due to embarrassment, feeling guilty or
disgusted by themselves after the binge) or C (e.g., marked distress
regarding binge eating for binge ED). The second was ‘‘any binge
eating”, also defined as (a) binge eating episodes (again, not requir-
ing DSM-IV criteria B and C), (b) occurring at least twice a week for
at least 3 months, but (c) lacking the hierarchical exclusion crite-
rion if the individual simultaneously exhibited another ED. In other
words, any binge eating was diagnosed regardless of whether or
not the individual simultaneously met criteria for any of the other
3 EDs or for sub-threshold binge ED. This entity therefore included
all cases of bulimia nervosa, binge ED, and sub-threshold binge ED,
as well as cases of anorexia nervosa with binge eating.
Table 1
Characteristics of the sample (N = 4139).
N % (95% CI)
Age groups
18–29 631 19.5 (17.6, 21.5)
30–44 1339 30.1 (28.0, 32.2)
45–64 1378 29.6 (27.6, 31.7)
65+ 791 20.8 (19.0, 22.9)
Gender
Male 1742 48.4 (46.1, 50.8)
Female 2397 51.6 (49.2, 53.9)
Education
0–12 years 2561 64.9 (62.7, 67.1)
+12 years 1578 35.1 (32.9, 37.3)
Marital status
Married/cohabiting 2729 66.1 (63.8, 68.4)
Previously married 614 11.1 (9.7, 12.7)
Never married 796 22.8 (20.8, 24.9)
Geographical area
Rural (<10,000) 1124 32.5 (30.2, 34.9)
Mid urban (10,000–100,000) 1872 39.6 (37.3, 42.0)
Large urban (>100,000) 1143 27.9 (25.7, 30.2)
Employment
Working 2259 55.2 (52.8, 57.5)
Homemaker 79 2.7 (2.0, 3.6)
Retired 478 9.9 (8.7, 11.2)
Unemployment 900 24.1 (22.1, 26.2)
Other 423 8.1 (6.9, 9.6)
Income
Low 737 18.9 (17.1, 20.8)
Low average 1233 30.5 (28.3, 32.7)
High average 1425 34.1 (31.9, 36.4)
High 744 16.5 (14.9, 18.3)
Country
Belgium 518 4.1 (3.5, 4.9)
France 466 14.5 (12.9, 16.2)
Germany 658 33.6 (31.5, 35.8)
Italy 900 24.2 (22.3, 26.1)
Netherlands 540 6.7 (5.8, 7.6)
Spain 1057 16.9 (15.5, 18.5)
A. Preti et al. / Journal of Psychiatric Research 43 (2009) 1125–1132 1127Its should be reminded that ‘‘any binge eating” is not a specific
diagnostic entity: however the investigation of genetic correlates
of EDs can greatly benefit from data at a phenotype level, and binge
eating, per se, has been demonstrated to be a feature of ED with a
large genetic component (Reichborn-Kjennerud et al., 2004). In
addition, EDs involving binge eating were found discontinuous
with normalcy (Williamson et al., 2005): therefore their identifica-
tion as a separate entity is justified.
We used data from the CIDI 3.0 regarding time of onset and re-
cency (i.e., the time when the disorder was last present) to apply
diagnostic hierarchies, so that bulimia nervosa, binge ED, and
sub-threshold binge ED were not diagnosed in the presence of an-
orexia nervosa; and so that binge ED and sub-threshold binge ED
were not diagnosed in the presence of bulimia nervosa.
On the other hand, we were unable to assess diagnostic cross-
over, a relatively frequent occurrence in EDs (Eddy et al., 2008;
Tozzi et al., 2005), since multiple episodes of EDs, including the
passage from anorexia nervosa to bulimia nervosa, could not be
properly addressed with hierarchical algorithms.
2.2.2. Short-term impairment
For individuals meeting criteria for any of the five disorders, the
CIDI 3.0 assessed: age of onset, recency, years with the disorder,
and professional help-seeking.
Respondents were additionally administered a modified version
of the WHODAS-II (the WHODAS-II for the WMH surveys) (Buist-
Bouwman et al., 2006; Chwastiak and Von Korff, 2003; Von Korff
et al., 2008), an instrument that evaluates five domains of function-
ing due to problems with either physical health, mental health, or
use of alcohol or drugs (Understanding and communicating; Self-
Care, Getting Around, Getting Along with Others, and Life Activi-
ties) over a 30-day recall period, and also were asked about life-
time treatment, and treatment in the past 12 months. Cut-off
point for severe impairment was defined as the 90‰ in the Global
Scale in the overall sample.
2.2.3. Service use
The use of services was assessed by asking all ESEMeD respon-
dents about past year service use for any problems with emotions,
nerves, or substance use by a psychiatrist, any other mental health
professional (e.g., clinical psychologist, psychiatric social worker), a
general medical health care provider, a non-medical professional
(e.g., religious counsellor, a social worker seen in at a social ser-
vices agency), and in the complementary-alternative medicine
(CAM) sector (either participation in a self-help group or treatment
by a CAM professional).
2.3. Statistical analyses
Lifetime and 12-month prevalence of EDs, comorbidity with
other mental disorders, disability and use of services were assessed
with cross-tabulations. The actuarial method was used to estimate
age of onset curves for each ED (Cox and Oakes, 1984). Discrete-
time survival analyses with person-years as the unit of analysis
using logistic regression were used to evaluate cohort differences
(Singer and Willett, 1993). Logistic regression models were carried
out to estimate the association (odds ratios) between each ED and
individual comorbid conditions; all reported ORs were adjusted by
age and sex.
The analysis for this paper was performed with SAS/STAT soft-
ware, Version 9.0 of the SAS System for Windows (Copyright 
2002–2003 SAS Institute Inc. Cary, NC, USA), and SUDAAN v9.0.1
(Research Triangle Institute, 2004), a statistical software used to
analyze data from complex sample surveys. Standard errors (SE)
and significance tests were estimated using the Taylor series line-
arization method (LaVange et al., 1996), a design-based methodimplemented in SUDAAN. Multivariate significance was evaluated
using Wald v2 tests based on design-corrected coefficient vari-
ance–covariance matrices. Statistical significance was evaluated
by using two-sided design-based tests, with an alpha level of 0.05.
Missing values of the items used to assess the presence of EDs
were imputed with Multiple Imputation, using the MI procedure
implemented in SAS and with five imputations (Little and Rubin,
1987). The analysis is then performed with SUDAAN V9.0.1, which
uses methods that incorporate appropriate variability across the
five imputations to generate valid statistical inferences about the
estimated parameters.
3. Results
The investigated sample included a balanced proportion of par-
ticipants by gender and age: mean age was 47.1 (95% CI 46.2–
48.0); young people (18–29 years old) were 20% of the study
sample. A third (35%) of the sample reported more than 12 years
of full-time education, and the majority (55%) were in paid
employment at the moment of the interview details on sampling
method and on characteristics of the investigated sample are
shown in Table 1.
3.1. Lifetime prevalence estimates for eating disorders
Lifetime prevalence estimates of anorexia nervosa, bulimia
nervosa, binge ED, sub-threshold binge ED, and any binge eating
were 0.48%, 0.51%, 1.12%, 0.72%, and 2.15%, respectively (Table 2).
Table 2
Lifetime and 12-month prevalence estimates of eating disorders in six European countries: general resultsa.
Males Females Total
N % (95% CI) N % (95% CI) N % (95% CI)
Lifetime prevalence
Anorexia nervosa 0 0% (–) 22 0.93% (0.5–1.6) 22 0.48% (0.3–0.8)
Bulimia nervosa 5 0.12% (0.0–0.4) 41 0.88% (0.6–1.4) 46 0.51% (0.3–0.8)
Binge eating disorder 12 0.26% (0.1–0.6) 64 1.92% (1.3–2.9) 77 1.12% (0.8–1.6)
Subthreshold binge eating disorder 13 0.91% (0.5–1.7) 16 0.55% (0.2–1.2) 29 0.72% (0.4–1.2)
Any binge eating disorder 29 1.22% (0.7–2.0) 112 3.03% (2.3–4.0) 140 2.15% (1.7–2.8)
Total: any eating disorderb 29 1.22% (0.7–2.0) 127 3.73% (2.9–4.8) 155 2.51% (2.0–3.2)
12-month prevalence
Anorexia nervosa 0 0% (–) 1 0.01% (0.0–0.0) 1 0% (0.0–0.0)
Bulimia nervosa 1 0.01% (0.0–0.1) 10 0.29% (0.1–0.7) 11 0.15% (0.1–0.4)
Binge eating disorder 4 0.07% (0.0–1.1) 24 0.55% (0.3–1.0) 28 0.31% (0.2–0.6)
Subthreshold binge eating disorder 3 0.19% (0.1–0.6) 0 0% (–) 3 0.09% (0.0–0.3)
Any binge eating disorder 8 0.26% (0.1–0.7) 34 0.8% (0.5–1.3) 42 0.54% (0.3–0.9)
Total: any eating disorderb 8 0.26% (0.1–0.7) 36 0.84% (0.5–1.4) 44 0.56% (0.4–0.9)
a Unweighted n, weighted %.
b Any eating disorder: anorexia nervosa or bulimia nervosa or binge eating or any binge eating disorder.
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women as men for all EDs, however defined, the only exception
being sub-threshold binge ED.
Lifetime prevalence estimates were higher in France (any ED:
4.15%, 95% CI 2.3–7.4) in Belgium (3.54%, 2.0–6.3) and in Italy
(3.35%, 2.2–5.0) as compared to the other three participating coun-
tries (Netherlands: 1.74%, 0.9–3.3; Germany: 1.28%, 0.8–2.1; Spain:
2.42%, 1.5–4.0). Germany and the Netherlands had the lowest esti-
mates of lifetime prevalence for anorexia nervosa; Germany and
Italy had the lowest estimates of lifetime prevalence for bulimia
nervosa. Only one case of 12-month anorexia nervosa (none among
males) was found in the sample. The 12-month prevalence esti-
mates of the other four disorders were considerably lower than
the lifetime estimates, although with similar sex ratios.
3.2. Cohort effect
We found a consistent inverse association between cohort (age
at interview) and lifetime risk: younger cohort had significantly
higher odds of receiving the diagnosis of an ED than the older
(Table 3).
Analysis of cumulative lifetime prevalence of EDs showed that
the majority of cases had their beginning between 10 and 20 years
old (Fig. 1). After 20 years old, no new case of anorexia nervosa oc-
curred, and only few cases of bulimia nervosa were reported. Binge
ED, on the other hand, continued to rise in prevalence until 40
years old, with a slight stepped additional rise after 60 years old.
3.3. Disability and role impairment
Twelve-month role impairment was assessed only for bulimia
nervosa, binge ED and any binge eating, since the lack of cases ofTable 3
Inter-cohort differences in lifetime risk of DSM-IV eating disordersa.
Anorexia nervosa Bulimia nervosa Binge eatin
Prevalence
(95% CI)
OR (95% CI) Prevalence
(95% CI)






































a Results based on discrete-time survival analysis with the person-year as the unit of
b OR based on a 0.05 level, two-sided test. The reference group is that of individualsanorexia nervosa prevented us from investigating this area in this
disorder. The majority of respondents reported at least some role
impairment on WHODAS-II disability scale in at least one role do-
main, with similar frequency of impairment in bulimia nervosa
(79.87% [95% CI: 43.5–95.3]), binge Ed (79.44% [95% CI: 42.0–
95.4]), and any binge eating (76.67% [95% CI: 51.8–90.9]). However,
severe role impairment was much less common, and respondents
with bulimia nervosa reported slightly (non-significant) less severe
role impairment (5.89% [95% CI: 1.2–24.9]) than those with binge
ED (26.9% [95% CI: 11.8–50.3]) or any binge eating (17.3% [95%
CI: 8.2–33.0]).
3.4. Co-occurrence with other DSM-IV mental disorders
EDs were significantly associated with a wide range of other
DSM–IV disorders. In the studied sample, 42.1% of respondents
with anorexia nervosa, 69.4% of those with bulimia nervosa and
62.2% of those with binge ED met criteria for at least one of the core
DSM-IV disorders assessed.
Any anxiety disorder was found in 33–40% of respondents with
any diagnosed ED; mood disorders were equally highly prevalent
in this group, with estimated prevalence ranging from 19% to
50% and over (data available on request).
3.5. Service use
A large proportion of those with a lifetime diagnosis of an ED re-
ported service use for emotional problems (Table 4). Respondents
with lifetime anorexia nervosa and bulimia nervosa were more
likely to have contacted some service for emotional problems than
those with sub-threshold disorders (sub-threshold binge ED and/or
any binge eating). Respondents with bulimia nervosa also wereg disorder Any binge eating Any eating disorder
OR (95% CI) Prevalence
(95% CI)

































analysis, adjusted by sex and count.
45 years or older.
Fig. 1. Cumulative lifetime prevalence of anorexia nervosa, bulimia nervosa, binge eating disorder, and any binge eating.
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with binge ED accessed complementary/alternative medicine pro-
fessionals (12%) more than those with any other ED (2–8%). As a
whole, the proportion of the respondents with a lifetime diagnosis
of ED who requested general medical treatment for emotional
problems was low: 48% among those with bulimia nervosa, 35%
among those with anorexia nervosa, less than 30% among those
with any other ED.
We found only one case of 12-month anorexia nervosa (none
among males) among the respondents. In the sample, around
60% of the respondents with 12-month bulimia nervosa reported
service use of some kind at the time of interview, less than 15%
in the mental health sector. The corresponding proportions for
binge ED were 28% and 15%, respectively. As a whole, less than
40% of those with a 12-month ED were in contact with some pro-
fessional at the time of interview, and among those in contact, the
majority were in contact with medical practitioners who were not
mental health specialists.
4. Discussion
This study confirms the substantial prevalence of EDs in the
general population of six major European countries. In our sample,
EDs are associated to a substantial comorbidity with other mental
disorders; however, the use of services among those affected peo-
ple is low, with a suboptimal utilization of the mental health sec-
tor. We found lifetime prevalence estimates as low as 0.5% for both
anorexia and bulimia nervosa, with significantly higher prevalence
among females than males. However, the male-to-female ratio in
the prevalence of these disorders (3–8) was consistently lower
than those reported in clinical case surveys, where, in general,
men account for less than 10% of cases (Fairburn and Beglin,
1990; Hoek and Van Hoeken, 2003). As a whole, these estimates,
as those of population-based studies, must be considered conser-
vative, since they involve very small numbers of cases of men with
EDs.
Comparison with past investigations is difficult: to date no lab-
oratory test can identify these diagnostic entities, and clinical
interviews still represent the best diagnostic tool. In the NEMESISstudy, which used a previous version of CIDI, lifetime prevalence
for anorexia and bulimia nervosa in Netherlands were twice as
high as those presently reported (Bijl et al., 1998). In the Sesto Fio-
rentino study, based on the Mini International Neuropsychiatric
Interview administered to 2355 respondents representative of
the population aged above 14 years living in Sesto Fiorentino (near
Florence, Italy), the estimated lifetime prevalence was 0.42% for
anorexia nervosa, 0.32% for bulimia nervosa, and 0.32% binge ED,
with the majority of cases among females (Faravelli et al., 2006).
In that study, however, a much higher proportion of subjects
(90–100%) meeting the criteria for any ED consulted their general
practitioner than in this study, and more than 50% contacted a psy-
chiatrist or a psychologist for their disorder.
Past studies which included the adolescent population found
higher prevalence for bulimia nervosa than in our study: from
1.1%, in a 15–17 years old Italian sample of school-aged students
(Santonastaso et al., 1996), to 1.2% in Sweden (Råstam et al.,
1989). However, prevalence similar, or lower than ours, have also
been reported in samples including adolescent respondents: from
0.2% among 2544 students aged 13–18 in the USA (Whitaker
et al., 1990), to 0.5% in Hong-Kong (N = 1020 students, 17–24 years
old) (Lee, 1993).
Our data are consistent with past investigations pointing to an
increase in the prevalence of EDs across time, particularly in the
second half of the 20th century (Bulik et al., 2006; Hoek and Van
Hoeken, 2003; Hudson et al., 2007; Kendler et al., 1991). Neverthe-
less, higher lifetime prevalence in the youngest cohort of cases
meeting DSM-IV criteria for anorexia or bulimia nervosa should
be taken with caution: recall of early experiences may diminish
with age, so any retrospective assessment may overestimate the
magnitude of cohort effect (Hudson et al., 2007). Moreover, cur-
rently EDs receive much more public attention, particularly in
the media, than in the past, and this may have created greater
attention, and so greater recall, for the symptoms indicative of
these disorders in the younger than in the older cohorts. Then,
EDs bear a very high risk of premature mortality (Patton, 1988;
Sullivan, 1995), and this may have contributed to unequal preva-
lence by cohort. Only prospective studies can really track cohort ef-



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1130 A. Preti et al. / Journal of Psychiatric Research 43 (2009) 1125–1132shown that in recent years (1995–2005) the increase has been real,
principally in the spectrum of eating disorders not otherwise spec-
ified (EDNOS) (Hay et al., 2008).
We found role impairment to be a rather widespread occur-
rence in EDs: although we were unable to investigate this issue
in anorexia nervosa, since only one 12-month case was identified
with that diagnosis, nevertheless more than 2/3 of those with
EDs had at least some role impairment in at least one role domain.
Severe role impairment, however, was much less frequent, with
cases with bulimia nervosa reporting less often severe impairment
on the WHODAS-II than those with binge ED, a pattern which is the
reverse of that found by Hudson and co-workers in the NCS-R
(Hudson et al., 2007). The low number of individuals with the dis-
orders and the use of an instrument more stringent for case defini-
tion, might explain this discrepancy.
4.1. Eating disorders, comorbidity and use of services
In the sample, more than half of the cases with any ED reported
some lifetime comorbid mental disorder. This finding is consistent
with past survey showing a high level of comorbidity in both clin-
ical samples (Godart et al., 2002; Halmi et al., 2005; Hudson et al.,
1987; Kaye et al., 2004; McElroy et al., 2005; Milos et al., 2003),
and in population-based studies (Bulik et al., 2002; Bushnell
et al., 1990; Garfinkel et al., 1995, 1996; Jacobi et al., 2004; Vollrath
et al., 1992) of anorexia nervosa, bulimia nervosa and binge ED. The
reason for this high level of comorbidity is not known, but genetic
factors are likely to play an important role, at least for the co-
occurrence of EDs with mood disorders (Ribasés et al., 2008; Wade
et al., 2000; Walters et al., 1992).
However, despite high comorbidity with other mental disor-
ders, which should enhance the search for new treatments (Jacobi
et al., 2004; Milos et al., 2003), only a scant proportion of cases
sought contact with mental health services for emotional prob-
lems: failure in recognizing ED in the medical setting (Hoek,
1991; Keski-Rahkonen et al., 2007), and the egosyntonic nature
of symptoms in most cases might contribute to the low degree of
service utilization among people with EDs (Fairburn and Harrison,
2003; Halmi et al., 2005).
4.2. Course of eating disorders
As in the NCS-R study (Hudson et al., 2007), we found that life-
time prevalence of EDs is substantially higher than the 12-month
prevalence, suggesting these disorders do not necessarily display
a chronic and unremitting course: a large fraction of those who
met the criteria for lifetime diagnosis of an ED did not report cur-
rent symptoms of the disorder in the most recent 12-month inter-
val. Recent studies found a 75% of recovery rate in anorexia
nervosa, although only less than 50% of diagnosed cases were to-
tally asymptomatic (60% in bulimia nervosa) (Jäger et al., 2004;
Wade et al., 2006). The introduction of specialized care units for
these disorders in some countries seems to have improved pa-
tients’ survival, particularly in anorexia nervosa (Lindblad et al.,
2006; Papadopoulos et al., 2009). However, it cannot be ruled out
that, due to the study method, the most severe cases of anorexia
and bulimia nervosa were not included in the study sample, since
they were hospitalized or unwilling to participate in an investiga-
tion on emotional problems.
4.3. Nosological relevance of binge eating disorders
As found in the NCS-R study (Hudson et al., 2007), binge ED is a
rather chronic and stable condition, associated to an even higher
chance of severe role impairment as compared to bulimia nervosa.
Binge ED was more common than the two currently recognized
A. Preti et al. / Journal of Psychiatric Research 43 (2009) 1125–1132 1131EDs (e.g., anorexia and bulimia nervosa) in all six investigated
countries, also showing a substantial comorbidity with other
DSM-IV mental disorders, particularly anxiety and mood disorders.
These findings seem to point to the importance of binge ED as an
autonomous ED, in need of appropriate public health attention.
Binge ED has a role in the development of obesity (Yanovski,
2003): indeed, recent consecutive population surveys found that
increasing prevalence of binge eating behaviours was associated
to a faster increasing comorbidity with obesity (Darby et al., 2009).
4.4. Limitations of the study
Our estimates should be considered lower-bound estimates of
EDs prevalence in the general population: our sample did not in-
clude people younger than 18 years old, who are those more likely
to develop symptoms of EDs.
The exclusion of people under 18 is probably the main reason
for the identification of just one case of anorexia nervosa in the last
12-months in our sample; another reason is the small sample size
of those in the immediately subsequent high-risk age band, aged
18–25 (on average, N = 100 by country). Although great care has
been put in the study design and in data collection, these limita-
tions make the study samples not closely representative of those
who can be seen in clinical settings with EDs.
These limitations may also contribute to the contradictory find-
ing of a similar prevalence between anorexia and bulimia nervosa.
In most studies, the prevalence of bulimia nervosa is about twice as
much as that of anorexia nervosa. In any event, other studies have
reported similar prevalence for both conditions (Råstam et al.,
1989; Whitaker et al., 1990).
Moreover, CIDI questions did not exactly match DSM-IV criteria
for EDs, diagnoses were based on lay interviews, and lifetime infor-
mation was assessed retrospectively. In addition, the most severe
cases of these disorders, those with severe forms of anorexia nerv-
osa or with severe psychiatric comorbidity in bulimia nervosa, are
both conditions likely to lead to hospitalization or to residential
care, and these settings were not included in the general popula-
tion sample to be recruited for interview. Another reason of low
prevalence in this study might be the stigma associated to the con-
dition: in non-clinical samples, measures of social desirability are
negatively related to the self-reporting of ED symptoms (Miotto
et al., 2002).
Willingness to participate, also, may have been uneven between
cases and non-cases: patients with anorexia and bulimia nervosa
have high dropout rates (Bacaltchuk et al., 2000; Halmi et al.,
2005), and it cannot be excluded that they are also less likely to
participate in a survey on emotional problems. Finally, because of
the use of a hierarchical algorithm in making the diagnoses, we
were unable to address the issue of diagnostic crossover, which
is relatively frequent in EDs (Eddy et al., 2008; Tozzi et al., 2005).
Despite these limitations, the study confirms the substantial
prevalence of EDs in the general population. It still has to be proven
whether early diagnostic identification and access to specialized
care can reduce the burden caused by these disorders (Striegel-
Moore et al., 2008).
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